Effect of Intraocular Lens (IOL) Centration and Tilt on Visual Performance With Clareon® Vivity® IOL Implantation

In by alicia.green

Locations
Jacksonville - Florida Eye Specialist (Gate)
Condition
Cataract, Ophthalmology

Effect of Intraocular Lens (IOL) Centration and Tilt on Visual Performance With Clareon® Vivity® IOL Implantation

  • Hidden
  • This field is for validation purposes and should be left unchanged.

A Non-Interventional Study to Evaluate the Effect of Intraocular Lens (IOL) Centration and Tilt on Visual Performance in Patients Who Have Undergone Clareon® Vivity® IOL Implantation

clinicaltrials.gov

Eligibility

Inclusion Criteria
  • Age ≥ 18 years
  • History of adult cataract and uneventful, refractive cataract surgery with Clareon® Vivity® or Vivity® Toric intraocular lens (IOL) implantation with manifest refraction spherical equivalent (MRSE) within ±1.00 D
  • Willing to undergo an eye exam with pupil dilation
Exclusion Criteria
  • Moderate to severe posterior capsule opacification (2+ or more)
  • Yttrium aluminum garnet (YAG) laser capsulotomy within 1 month prior to enrollment
  • Laser-assisted in situ keratomileusis (LASIK) or photorefractive keratectomy (PRK) within the one year prior to IOL implantation or any time after IOL implantation
  • Any previous ocular surgery (excluding YAG, LASIK, PRK)
  • Clinically significant ocular pathology; severe diabetic retinopathy, age-related macular degeneration (AMD), glaucoma, severe dry eye, irregular astigmatism, zonular weakness, pseudoexfoliation, ocular trauma
  • Any additional procedure(s) at the same time as the Vivity implantation including but not limited to microinvasive glaucoma surgery (MIGS)
  • Women who are pregnant at the time of screening (based on self-reported history)
  • Medical or other problems which in the opinion of the investigator will render study participation unsafe
Back to Current Studies